BRIEF-Sanofi initiates phase 2 clinical trial
February 14, 2017 at 08:29 AM EST
* Sanofi initiates phase 2 clinical trial to evaluate therapy for genetic form of parkinson's disease Source text for Eikon: Further company coverage:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.